Thorne Healthtech Inc
NASDAQ:THRN
P/FCFE
Price to FCFE
Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
Market Cap | P/FCFE | ||||
---|---|---|---|---|---|
US |
T
|
Thorne Healthtech Inc
NASDAQ:THRN
|
549.4m USD | 125.9 | |
FR |
L'Oreal SA
PAR:OR
|
244.3B EUR | 29 | ||
UK |
Unilever PLC
LSE:ULVR
|
107.2B GBP | 17.6 | ||
IN |
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.5T INR | 40.9 | ||
US |
Estee Lauder Companies Inc
NYSE:EL
|
48.2B USD | -49.1 | ||
UK |
HALEON PLC
LSE:HLN
|
30.3B GBP | 34.3 | ||
DE |
Beiersdorf AG
XETRA:BEI
|
32.9B EUR | 206.8 | ||
JP |
Kao Corp
TSE:4452
|
3.2T JPY | 26.1 | ||
IN |
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.3T INR | 34 | ||
JP |
Shiseido Co Ltd
TSE:4911
|
1.9T JPY | -12 497.4 | ||
IN |
Dabur India Ltd
NSE:DABUR
|
984B INR | 55.5 |
P/FCFE Forward Multiples
Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.